Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

173 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Biology of the sauropod dinosaurs: the evolution of gigantism.
Sander PM, Christian A, Clauss M, Fechner R, Gee CT, Griebeler EM, Gunga HC, Hummel J, Mallison H, Perry SF, Preuschoft H, Rauhut OW, Remes K, Tütken T, Wings O, Witzel U. Sander PM, et al. Among authors: Remes K. Biol Rev Camb Philos Soc. 2011 Feb;86(1):117-55. doi: 10.1111/j.1469-185X.2010.00137.x. Biol Rev Camb Philos Soc. 2011. PMID: 21251189 Free PMC article. Review.
Real-world treatment outcomes in multiple myeloma: Multicenter registry results from Finland 2009-2013.
Remes K, Anttila P, Silvennoinen R, Putkonen M, Ollikainen H, Terävä V, Sinisalo M, Kananen K, Schain F, Castren-Kortegangas P, Järvinen TM, Pisini M, Wahl F, Dixon T, Leval A. Remes K, et al. PLoS One. 2018 Dec 5;13(12):e0208507. doi: 10.1371/journal.pone.0208507. eCollection 2018. PLoS One. 2018. PMID: 30517181 Free PMC article. Clinical Trial.
Severe neutropenia after rituximab-treatment of multiple sclerosis.
Rissanen E, Remes K, Airas L. Rissanen E, et al. Among authors: Remes K. Mult Scler Relat Disord. 2018 Feb;20:3-5. doi: 10.1016/j.msard.2017.12.005. Epub 2017 Dec 12. Mult Scler Relat Disord. 2018. PMID: 29253744
A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation.
Törlén J, Ringdén O, Garming-Legert K, Ljungman P, Winiarski J, Remes K, Itälä-Remes M, Remberger M, Mattsson J. Törlén J, et al. Among authors: Remes K. Haematologica. 2016 Nov;101(11):1417-1425. doi: 10.3324/haematol.2016.149294. Epub 2016 Aug 4. Haematologica. 2016. PMID: 27662016 Free PMC article. Clinical Trial.
HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemia.
Kontro M, Kumar A, Majumder MM, Eldfors S, Parsons A, Pemovska T, Saarela J, Yadav B, Malani D, Fløisand Y, Höglund M, Remes K, Gjertsen BT, Kallioniemi O, Wennerberg K, Heckman CA, Porkka K. Kontro M, et al. Among authors: Remes K. Leukemia. 2017 Feb;31(2):301-309. doi: 10.1038/leu.2016.222. Epub 2016 Aug 8. Leukemia. 2017. PMID: 27499136
173 results
Jump to page